Canaccord Genuity Maintains Hold on Edwards Lifesciences, Raises Price Target to $89

Benzinga · 1d ago
Canaccord Genuity analyst William Plovanic maintains Edwards Lifesciences (NYSE:EW) with a Hold and raises the price target from $84 to $89.